AKR1B1 and neoplasm: Simultaneous expression of AKR1B1 was noticed in individual mixed-lineage tumor cells comprised of different histological subtypes of NSCLC underscoring the value of this protein as a candidate target for therapeutic intervention of these tumors [27].